Unknown

Dataset Information

0

Disulfide bond stabilization of the hexameric capsomer of human immunodeficiency virus.


ABSTRACT: The human immunodeficiency virus type 1 capsid is modeled as a fullerene cone that is composed of approximately 250 hexamers and 12 pentamers of the viral CA protein. Structures of CA hexamers have been difficult to obtain because the hexamer-stabilizing interactions are inherently weak, and CA tends to spontaneously assemble into capsid-like particles. Here, we describe a two-step biochemical strategy to obtain soluble CA hexamers for crystallization. First, the hexamer was stabilized by engineering disulfide cross-links (either A14C/E45C or A42C/T54C) between the N-terminal domains of adjacent subunits. Second, the cross-linked hexamers were prevented from polymerizing further into hyperstable capsid-like structures by mutations (W184A and M185A) that interfered with dimeric association between the C-terminal domains that link adjacent hexamers. The structures of two different cross-linked CA hexamers were nearly identical, and we combined the non-mutated portions of the structures to generate an atomic resolution model for the native hexamer. This hybrid approach for structure determination should be applicable to other viral capsomers and protein-protein complexes in general.

SUBMITTER: Pornillos O 

PROVIDER: S-EPMC3050670 | biostudies-literature | 2010 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Disulfide bond stabilization of the hexameric capsomer of human immunodeficiency virus.

Pornillos Owen O   Ganser-Pornillos Barbie K BK   Banumathi Sankaran S   Hua Yuanzi Y   Yeager Mark M  

Journal of molecular biology 20100626 5


The human immunodeficiency virus type 1 capsid is modeled as a fullerene cone that is composed of approximately 250 hexamers and 12 pentamers of the viral CA protein. Structures of CA hexamers have been difficult to obtain because the hexamer-stabilizing interactions are inherently weak, and CA tends to spontaneously assemble into capsid-like particles. Here, we describe a two-step biochemical strategy to obtain soluble CA hexamers for crystallization. First, the hexamer was stabilized by engine  ...[more]

Similar Datasets

| S-EPMC2575144 | biostudies-literature
| S-EPMC154041 | biostudies-literature
| S-EPMC154040 | biostudies-literature
| S-EPMC3332088 | biostudies-literature
| S-EPMC3953729 | biostudies-literature
| S-EPMC136243 | biostudies-literature
| S-EPMC7736355 | biostudies-literature
| PRJNA287455 | ENA
| PRJNA279269 | ENA
| PRJNA387132 | ENA